av/sun-pharmaceutical--big.svg

NSE:SUNPHARMA

Sun Pharmaceutical Industries Ltd.

  • Stock

INR

Last Close

1,832.30

02/05 08:51

Market Cap

3.80T

Beta: 0.39

Volume Today

1.80M

Avg: 2.06M

PE Ratio

39.50

PFCF: -

Dividend Yield

0.79%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
43.95B
-
60.46B
37.55%
66.28B
9.63%
68.57B
3.45%
73.83B
7.68%
78.80B
6.73%
84.36B
7.05%
89.97B
6.65%
97.55B
8.43%
104.04B
6.65%
102.69B
1.30%
average payables
22.41B
-
33.22B
48.22%
39.42B
18.69%
45.81B
16.19%
44.57B
2.70%
41.21B
7.54%
40.34B
2.11%
42.27B
4.78%
50.80B
20.20%
56.67B
11.55%
59.19B
4.44%
average receivables
56.73B
-
87.36B
54.00%
102.23B
17.03%
107.50B
5.15%
113.48B
5.57%
123.46B
8.79%
122.86B
0.48%
125.70B
2.31%
124.05B
1.31%
113.59B
8.44%
121.53B
7.00%
book value per share
106.61
-
130.51
22.42%
152.45
16.82%
158.80
4.16%
172.59
8.68%
188.65
9.31%
193.65
2.65%
200.10
3.33%
233.27
16.58%
279.69
19.90%
302.44
8.14%
capex per share
-9.84
-
-14.06
42.88%
-15.37
9.32%
-8.17
46.81%
-13.39
63.85%
-6.43
52.00%
-4.88
24.12%
-6.23
27.77%
-8.69
39.44%
9.18
205.62%
8.88
3.22%
capex to depreciation
-1.98
-
-3.34
68.53%
-2.92
12.51%
-1.31
55.23%
-1.83
40.17%
-0.75
59.01%
-0.56
25.11%
-0.70
23.97%
-0.82
18.23%
0.86
204.44%
0.83
4.02%
capex to operating cash flow
-0.44
-
-0.50
12.40%
-0.52
4.35%
-0.50
3.76%
-1.46
191.47%
-0.24
83.92%
-0.19
19.39%
-0.17
12.25%
-0.42
152.72%
0.18
143.15%
0.15
16.63%
capex to revenue
-0.09
-
-0.12
40.67%
-0.12
0.95%
-0.08
38.90%
-0.11
48.88%
-0.05
57.41%
-0.04
25.98%
-0.04
10.19%
-0.05
23.86%
0.05
195.67%
0.04
12.19%
cash per share
54.54
-
61.11
12.05%
63.87
4.53%
58.25
8.80%
46.59
20.02%
45.60
2.14%
39.86
12.58%
52.74
32.33%
66.27
25.64%
80.56
21.56%
104.26
29.42%
days of inventory on hand
266.06
-
313.01
17.65%
264.62
15.46%
284.56
7.53%
311.56
9.49%
274.50
11.89%
332.20
21.02%
280.49
15.57%
359.90
28.31%
151.44
57.92%
347.88
129.71%
days payables outstanding
148.04
-
170.04
14.86%
170.22
0.11%
197.11
15.80%
163.87
16.86%
142.70
12.92%
146.72
2.82%
139.65
4.82%
194.50
39.28%
83.16
57.24%
210.03
152.55%
days sales outstanding
104.05
-
127.59
22.62%
130.85
2.56%
150.50
15.01%
152.04
1.03%
143.88
5.37%
130.31
9.43%
126.42
2.98%
97.00
23.27%
86.06
11.28%
90.57
5.24%
debt to assets
0.18
-
0.16
14.26%
0.16
1.63%
0.16
0.88%
0.16
0.63%
0.12
25.04%
0.06
53.07%
0.02
67.67%
0.09
361.59%
0.03
60.98%
0.03
22.97%
debt to equity
0.35
-
0.27
22.59%
0.27
1.33%
0.27
1.58%
0.25
6.85%
0.18
27.65%
0.08
54.67%
0.03
67.72%
0.12
357.82%
0.04
63.67%
0.03
26.82%
dividend yield
0.00
-
0.00
190.06%
0.00
60.34%
0.01
351.53%
0.00
36.19%
0.02
290.40%
0.01
33.36%
0.01
9.53%
0.01
8.51%
0.01
30.54%
0.01
19.76%
earnings yield
0.02
-
0.02
29.64%
0.04
76.20%
0.02
57.87%
0.02
30.78%
0.04
91.99%
0.02
64.24%
0.01
6.39%
0.04
140.80%
0.02
31.77%
0.03
9.60%
enterprise value
2.48T
-
1.98T
20.25%
1.67T
15.77%
1.24T
25.36%
1.18T
4.80%
871.67B
26.34%
1.41T
61.79%
2.16T
53.35%
2.38T
10.17%
3.85T
61.55%
3.98T
3.42%
enterprise value over ebitda
30.80
-
22.91
25.62%
15.70
31.44%
20.18
28.53%
16.45
18.50%
11.60
29.50%
15.58
34.30%
18.64
19.68%
19.40
4.06%
27.82
43.39%
26.39
5.14%
ev to operating cash flow
46.59
-
29.21
37.30%
23.52
19.49%
31.82
35.29%
53.88
69.35%
13.30
75.32%
22.86
71.87%
24.07
5.31%
48.04
99.59%
31.72
33.98%
28.29
10.81%
ev to sales
9.09
-
7.13
21.54%
5.55
22.12%
4.77
14.11%
4.13
13.50%
2.70
34.64%
4.26
57.82%
5.63
32.25%
5.51
2.18%
8.06
46.40%
7.57
6.06%
free cash flow per share
12.29
-
14.07
14.51%
14.10
0.20%
8.11
42.48%
-4.24
152.22%
20.89
593.20%
20.84
0.25%
31.21
49.78%
11.97
61.65%
41.40
245.81%
49.83
20.37%
free cash flow yield
0.01
-
0.02
42.98%
0.02
19.40%
0.02
22.06%
-0.01
155.38%
0.06
770.36%
0.03
41.21%
0.03
2.12%
0.01
64.31%
0.03
108.67%
0.03
15.47%
graham net net
5.17
-
26.83
418.55%
24.35
9.25%
13.17
45.92%
17.14
30.17%
22.11
29.01%
19.79
10.51%
35.02
76.94%
34.83
0.52%
60.70
74.26%
84.61
39.39%
graham number
212.78
-
239.89
12.74%
315.28
31.43%
179.41
43.09%
207.70
15.76%
258.08
24.26%
203.69
21.08%
247.81
21.66%
430.44
73.69%
488.15
13.41%
556.02
13.90%
income quality
0.83
-
1.00
20.39%
0.78
21.77%
1.12
43.48%
0.58
48.67%
1.31
126.98%
2.20
68.46%
2.00
9.04%
0.53
73.71%
1.27
140.40%
1.29
1.61%
intangibles to total assets
0.13
-
0.16
27.80%
0.17
4.72%
0.17
1.68%
0.19
14.09%
0.19
1.12%
0.18
6.15%
0.18
2.05%
0.22
23.99%
0.20
9.58%
0.20
3.47%
interest coverage
37.92
-
30.92
18.44%
25.88
16.31%
9.05
65.02%
9.00
0.63%
18.80
109.02%
49.43
162.90%
74.26
50.23%
56.70
23.65%
43.90
22.58%
54.07
23.19%
interest debt per share
38.20
-
36.50
4.47%
42.28
15.86%
45.17
6.82%
46.01
1.87%
35.87
22.05%
16.71
53.41%
5.91
64.64%
29.42
397.89%
12.85
56.31%
10.82
15.82%
inventory turnover
1.37
-
1.17
15.00%
1.38
18.29%
1.28
7.01%
1.17
8.66%
1.33
13.50%
1.10
17.37%
1.30
18.44%
1.01
22.06%
2.41
137.64%
1.05
56.47%
invested capital
0.35
-
0.27
22.59%
0.27
1.33%
0.27
1.58%
0.25
6.85%
0.18
27.65%
0.08
54.67%
0.03
67.72%
0.12
357.82%
550.14B
447,123,392,947,970%
636.61B
15.72%
market cap
2.46T
-
1.97T
19.87%
1.65T
16.19%
1.22T
26.32%
1.15T
5.71%
845.29B
26.43%
1.43T
69.68%
2.19T
53.02%
2.36T
7.52%
3.91T
65.65%
4.07T
4.13%
net current asset value
85.83B
-
121.35B
41.38%
119.74B
1.33%
93.18B
22.18%
110.98B
19.10%
125.26B
12.87%
122.55B
2.17%
162.81B
32.85%
184.34B
13.22%
250.76B
36.03%
330.10B
31.64%
net debt to ebitda
0.21
-
0.05
77.17%
0.11
125.74%
0.40
262.39%
0.48
20.14%
0.35
26.85%
-0.27
175.65%
-0.28
4.45%
0.18
166.51%
-0.43
335.50%
-0.59
36.83%
net income per share
18.88
-
19.60
3.83%
28.98
47.87%
9.01
68.91%
11.11
23.31%
15.69
41.25%
9.52
39.32%
13.64
43.25%
35.30
158.79%
39.91
13.07%
45.60
14.25%
operating cash flow per share
22.13
-
28.13
27.12%
29.47
4.75%
16.28
44.74%
9.15
43.78%
27.32
198.42%
25.72
5.86%
37.45
45.61%
20.66
44.83%
50.58
144.80%
58.71
16.09%
payables turnover
2.47
-
2.15
12.94%
2.14
0.11%
1.85
13.64%
2.23
20.28%
2.56
14.84%
2.49
2.74%
2.61
5.06%
1.88
28.20%
4.39
133.87%
1.74
60.40%
receivables turnover
3.51
-
2.86
18.45%
2.79
2.50%
2.43
13.05%
2.40
1.02%
2.54
5.68%
2.80
10.41%
2.89
3.08%
3.76
30.33%
4.24
12.71%
4.03
4.98%
research and ddevelopement to revenue
0.07
-
0.06
8.40%
return on tangible assets
0.11
-
0.10
2.11%
0.14
31.59%
0.04
70.46%
0.05
26.12%
0.07
33.53%
0.04
39.65%
0.06
39.48%
0.14
136.28%
0.14
3.91%
0.15
4.98%
revenue per share
113.46
-
115.25
1.57%
124.80
8.29%
108.64
12.95%
119.56
10.06%
134.73
12.68%
138.12
2.52%
160.15
15.95%
180.30
12.58%
199.05
10.40%
219.38
10.21%
roe
0.18
-
0.15
15.19%
0.19
26.58%
0.06
70.15%
0.06
13.46%
0.08
29.22%
0.05
40.88%
0.07
38.63%
0.15
122.00%
0.15
0.60%
0.15
0.61%
roic
0.17
-
0.16
5.16%
0.16
0.95%
0.06
59.99%
0.08
20.10%
0.08
10.76%
0.11
32.65%
0.14
28.85%
0.14
2.71%
0.14
2.74%
0.13
3.94%
sales general and administrative to revenue
0.06
-
0.08
26.95%
0.06
27.25%
0.07
27.46%
0.06
16.52%
0.07
16.56%
0.07
4.42%
0.06
20.93%
0.07
-
shareholders equity per share
106.61
-
130.51
22.42%
152.45
16.82%
158.80
4.16%
172.59
8.68%
188.65
9.31%
193.65
2.65%
200.10
3.33%
233.27
16.58%
265.35
13.75%
301.32
13.56%
stock based compensation to revenue
0.00
-
0.00
52.58%
0.00
69.77%
-0.00
103.56%
tangible asset value
222.75B
-
267.08B
19.90%
300.14B
12.38%
312.60B
4.15%
324.13B
3.69%
362.84B
11.94%
375.32B
3.44%
384.88B
2.55%
412.76B
7.24%
498.41B
20.75%
545.26B
9.40%
tangible book value per share
92.62
-
110.99
19.83%
124.89
12.52%
130.29
4.33%
135.09
3.69%
151.22
11.94%
156.42
3.44%
160.41
2.55%
171.95
7.19%
207.73
20.81%
227.50
9.52%
working capital
127.69B
-
176.17B
37.97%
150.67B
14.48%
117.72B
21.87%
137.30B
16.63%
159.48B
16.16%
142.96B
10.35%
178.14B
24.61%
199.56B
12.02%
264.49B
32.54%
344.30B
30.18%

All numbers in INR (except ratios and percentages)